This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $4,393.88 and a period of performance through November 1, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award is part of AmerisourceBergen's extensive federal contract portfolio with the DLA and other agencies, demonstrating the company's critical role in supplying essential medical commodities to the U.S. government.
Generated 2/27/25, 10:52 AM